[go: up one dir, main page]

IL186935A0 - Prostate cancer field effect analysis methods and kits - Google Patents

Prostate cancer field effect analysis methods and kits

Info

Publication number
IL186935A0
IL186935A0 IL186935A IL18693507A IL186935A0 IL 186935 A0 IL186935 A0 IL 186935A0 IL 186935 A IL186935 A IL 186935A IL 18693507 A IL18693507 A IL 18693507A IL 186935 A0 IL186935 A0 IL 186935A0
Authority
IL
Israel
Prior art keywords
kits
field effect
prostate cancer
analysis methods
effect analysis
Prior art date
Application number
IL186935A
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Publication of IL186935A0 publication Critical patent/IL186935A0/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL186935A 2006-10-31 2007-10-25 Prostate cancer field effect analysis methods and kits IL186935A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85564006P 2006-10-31 2006-10-31

Publications (1)

Publication Number Publication Date
IL186935A0 true IL186935A0 (en) 2008-02-09

Family

ID=38969822

Family Applications (1)

Application Number Title Priority Date Filing Date
IL186935A IL186935A0 (en) 2006-10-31 2007-10-25 Prostate cancer field effect analysis methods and kits

Country Status (8)

Country Link
EP (1) EP1918711A3 (en)
JP (1) JP2008113659A (en)
KR (1) KR20080039323A (en)
CN (1) CN101270388A (en)
BR (1) BRPI0705819A (en)
CA (1) CA2606589A1 (en)
IL (1) IL186935A0 (en)
MX (1) MX2007013726A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102016067A (en) * 2008-01-22 2011-04-13 维里德克斯有限责任公司 Detection of GSTP1 hypermethylation in prostate cancer
WO2010017301A1 (en) * 2008-08-05 2010-02-11 Veridex, Llc Prostate cancer methylation assay
ATE547403T1 (en) 2008-08-15 2012-03-15 Univ Georgetown FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
GB9609441D0 (en) 1996-05-04 1996-07-10 Zeneca Ltd Process
GB9812768D0 (en) 1998-06-13 1998-08-12 Zeneca Ltd Methods
CA2438943C (en) * 2001-02-23 2019-05-14 Dana-Farber Cancer Institute, Inc. Hin-1, a tumor suppressor gene
EP1456413B1 (en) * 2001-11-16 2008-04-23 The Johns Hopkins University School Of Medicine Method of detection of prostate cancer

Also Published As

Publication number Publication date
MX2007013726A (en) 2009-02-19
BRPI0705819A (en) 2008-06-24
KR20080039323A (en) 2008-05-07
CA2606589A1 (en) 2008-04-30
EP1918711A3 (en) 2008-07-09
JP2008113659A (en) 2008-05-22
CN101270388A (en) 2008-09-24
EP1918711A2 (en) 2008-05-07

Similar Documents

Publication Publication Date Title
EP2074422A4 (en) Methods and kits for detecting prostate cancer biomarkers
EP2061899A4 (en) BIOMARKERS OF PROSTATE CANCER AND METHODS USING THEM
EP1922326A4 (en) Biomarkers useful for diagnosing prostate cancer, and methods thereof
EP2156184A4 (en) Methods for diagnosing and treating prostate and lung cancer
ZA200901615B (en) Compositions and methods for diagnosing and treating cancer
HK1140944A1 (en) Methods and compositions for treating recurrent cancer
EP2032166A4 (en) Compositions and methods for diagnosing and treating cancer
EP2069523A4 (en) Methods and devices for analyzing small rna molecules
GB0603295D0 (en) Methods and kits
PL2173379T3 (en) Compositions and methods for treating and diagnosing cancer
ZA201101132B (en) Signatures and pcdeterminants associated with prostate cancer and methods of use thereof
EP2073728A4 (en) Biopsy devices and related methods
GB0521521D0 (en) Diagnostic methods and kits
EP2125887A4 (en) Compositions and methods for diagnosing and treating cancer
EP2155249A4 (en) Compositions and methods for diagnosing and treating cancer
EP1977247A4 (en) Methods for diagnosing and treating prostate cancer
PL1858929T3 (en) Diagnosis of prostate cancer
IL186980A0 (en) Characterizing prostate cancer
ZA200705280B (en) Cancer markers and detection methods
EP2099491A4 (en) Compositions and methods for diagnosing and treating cancer
GB0618429D0 (en) Cancer test
EP2137213A4 (en) Methods and compositions for treating prostate cancer
IL186935A0 (en) Prostate cancer field effect analysis methods and kits
EP2146208A4 (en) Kit for deciding degree of malignancy in prostate cancer and method of using the same
SG10201701286YA (en) Cancer detection methods and techniques